Voyager Therapeutics, Inc. (VYGR) › Total LiabilitiesVoyager Therapeutics, Inc. (VYGR) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $10.35M2015: $60.38M2016: $53.64M2017: $50.43M2018: $130.58M2019: $255.25M2020: $107.26M2021: $98.80M2022: $100.34M2023: $114.96M2024: $93.29M2025: $56.20M$56.20M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$56.20M-39.8%2024$93.29M-18.9%2023$114.96M+14.6%2022$100.34M+1.6%2021$98.80M-7.9%2020$107.26M-58.0%2019$255.25M+95.5%2018$130.58M+159.0%2017$50.43M-6.0%2016$53.64M-11.2%2015$60.38M+483.5%2014$10.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share